Document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 11-K
(Mark One)
 ýANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2020
OR
 
 ¨TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission file number 001-37702
THE RETIREMENT AND SAVINGS PLAN FOR
AMGEN MANUFACTURING, LIMITED
State Road 31, Kilometer 24.6, Juncos, Puerto Rico 00777
(Full title and address of the plan)
AMGEN INC.
(Name of issuer of the securities held)
 
One Amgen Center Drive, 91320-1799
Thousand Oaks, California (Zip Code)
(Address of principal executive offices) 





The Retirement and Savings Plan for
Amgen Manufacturing, Limited

Audited Financial Statements
and Supplemental Schedule
Year Ended December 31, 2020

Contents
 
Audited Financial Statements:
Supplemental Schedule:




Report of Independent Registered Public Accounting Firm

To the Plan Participants and the Plan Administrator of The Retirement and Savings Plan for Amgen Manufacturing, Limited
Opinion on the Financial Statements
We have audited the accompanying statements of net assets available for benefits of The Retirement and Savings Plan for Amgen Manufacturing, Limited (the Plan) as of December 31, 2020 and 2019, and the related statement of changes in net assets available for benefits for the year ended December 31, 2020, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the net assets available for benefits of the Plan at December 31, 2020 and 2019, and the changes in its net assets available for benefits for the year ended December 31, 2020, in conformity with U.S. generally accepted accounting principles.
Basis for Opinion
These financial statements are the responsibility of the Plan’s management. Our responsibility is to express an opinion on the Plan’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Plan’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Supplemental Schedule
The accompanying supplemental schedule of assets (held at end of year) as of December 31, 2020, has been subjected to audit procedures performed in conjunction with the audit of the Plan’s financial statements. The information in the supplemental schedule is the responsibility of the Plan’s management. Our audit procedures included determining whether the information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental schedule. In forming our opinion on the information, we evaluated whether such information, including its form and content, is presented in conformity with the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the information is fairly stated, in all material respects, in relation to the financial statements as a whole.
/s/ ERNST & YOUNG LLP
We have served as the Plan’s auditor since 1992.
Los Angeles, California
June 22, 2021
1



The Retirement and Savings Plan for Amgen Manufacturing, Limited
Statements of Net Assets Available for Benefits

 December 31,
 20202019
Assets
Investments at fair value$597,881,242 $527,261,698 
Notes receivable from participants13,717,037 15,872,871 
Other – principally due from broker302,168 494,029 
Total assets611,900,447 543,628,598 
Liabilities
Other – principally due to broker285,774 581,092 
Total liabilities285,774 581,092 
Net assets available for benefits$611,614,673 $543,047,506 
See accompanying notes.
2



The Retirement and Savings Plan for Amgen Manufacturing, Limited
Statement of Changes in Net Assets Available for Benefits

 Year Ended December 31,
 2020
Additions to (deductions from) net assets:
Employer contributions$18,606,486 
Participant contributions17,903,354 
Rollover contributions354,877 
Interest and dividend income4,674,319 
Net realized/unrealized gains63,575,527 
Interest income on notes receivable from participants789,216 
Benefits paid(36,610,267)
Investment and administrative fees(726,345)
Net increase68,567,167 
Net assets available for benefits at beginning of year543,047,506 
Net assets available for benefits at end of year$611,614,673 
See accompanying notes.
3



The Retirement and Savings Plan for Amgen Manufacturing, Limited
Notes to Financial Statements
December 31, 2020

1. Description of the Plan
The following description of The Retirement and Savings Plan for Amgen Manufacturing, Limited (the Plan) provides only general information. Participants should refer to the Plan document for a more complete description of the Plan’s provisions.
General
The Plan was established effective May 1, 1992, and was amended and restated effective January 1, 2017, and subsequently amended, with the most recent amendment adopted on December 6, 2020. The Plan is a defined contribution plan covering substantially all Puerto Rico resident employees of Amgen Manufacturing, Limited (the Company), a wholly owned subsidiary of Amgen Inc. (Amgen). The Plan is intended to qualify under Section 1081.01 of the Puerto Rico Internal Revenue Code of 2011, as amended (the PR Code) (see Note 4, Income Tax Status) and section 407(d)(3)(A) of the Employee Retirement Income Security Act of 1974 (ERISA).
Contributions
Subject to certain limitations (as defined in the Plan), participants may elect to contribute up to 30% of their eligible compensation in pre-tax contributions and after-tax contributions or a combination of these types of contributions (together, Individual Contributions). A participant’s pre-tax contributions are subject to PR Code and Plan limitations and could not exceed $15,000 in 2020. Participants may elect to contribute after-tax contributions beginning January 1 of the year following the year the participant was hired. Participant after-tax contributions are subject to PR Code and Plan limitations and could not exceed $1,500 in 2020. Unless an employee has voluntarily enrolled in the Plan or has declined to participate in the Plan within the first 30 days of employment, all newly eligible participants are automatically enrolled in the Plan, and contributions equal to 5% of their eligible compensation are withheld and contributed to the Plan as pre-tax contributions; such contributions are automatically increased by 1% per year until their contributions reach 10% of their eligible compensation. Participants may elect to adjust, cease or resume their Individual Contributions at any time.
Participants who are at least age 50 by the close of the Plan year may also elect to make certain additional pre-tax Individual Contributions, referred to as catch-up contributions, that are subject to PR Code and Plan limitations and could not exceed $1,500 in 2020. Participants may also contribute pre-tax and after-tax amounts representing distributions from certain other retirement plans qualified in Puerto Rico, referred to as rollover contributions (as defined in the Plan).
Each pay period, the Company makes a non-elective contribution for all eligible participants, whether or not they have elected to make Individual Contributions to the Plan, equal to 4% of each participant’s eligible compensation up to a maximum of $11,400 in 2020 (Core Contributions). In addition, the Company makes a contribution equal to amounts contributed by the participant as pre-tax contributions, including catch-up contributions, of up to 5% of eligible compensation (Matching Contributions). Matching Contributions could not exceed $14,250 in 2020.
Participants select the investments in which their Individual Contributions, including their Core Contributions and Matching Contributions (collectively, Company Contributions), are to be invested, electing among various alternatives, including Amgen common stock (Amgen stock). Participants may direct a maximum of 20% of contributions to be invested in Amgen stock. In addition, participants may transfer amounts among the investment options at any time, subject to certain limitations. Notwithstanding the foregoing, if 20% or more of the value of a participant’s Plan account is invested in Amgen stock, the Plan document provides that no transfers from other investment options can be made to invest in Amgen stock.
The accounts of participants who had never made an investment election are allocated to investments under a qualified default investment alternative, which is intended to be compliant with ERISA regulations. At any time, participants may elect to alter the investments in their accounts made under a qualified default investment alternative.
4



The Retirement and Savings Plan for Amgen Manufacturing, Limited
Notes to Financial Statements (continued)

Vesting
Participants are immediately vested with respect to their Individual Contributions and Matching Contributions and earnings and losses (hereafter referred to as earnings) thereon. Participants hired prior to January 1, 2020, are also immediately vested with respect to their Core Contributions and earnings thereon. Participants hired on or after January 1, 2020, vest in full with respect to their Core Contributions and earnings thereon after three years of service, as defined by the terms of the Plan, or upon reaching age 65 while employed by the Company, if earlier. If a participant ceases to be an employee before fully vesting in their account, the non-vested portion of the participant’s account will be treated as a forfeiture, as defined by the terms of the Plan, on the earlier of (a) the date the participant incurs a five-year break in service, as defined by the terms of the Plan or, (b) the date the participant receives a distribution of the entire vested portion of their account.
Participant Accounts
Each participant’s account is credited with: (a) the participant’s Individual Contributions; (b) an allocation of Company Contributions; and (c) earnings. The benefit to which a participant is entitled is the benefit that can be provided from the participant’s account.
Plan Investments
From January 1 through November 20, 2020, Plan participants could invest in 16 different asset classes as well as Amgen stock or could actively manage their account under a self-directed brokerage arrangement in which a wider array of investment options are available. Effective beginning Monday, November 23, 2020, the investment options available to Plan participants were streamlined from 16 to seven different asset classes, and existing participant account balances and future contributions were allocated among these seven asset classes. In addition, participants could continue to invest in Amgen stock or actively manage their account under the self-directed brokerage arrangement. The value of an investment in an asset class is determined by its underlying investment vehicles, which may include one or more of the following: mutual funds, collective trust funds and portfolios, which are separately managed exclusively for the benefit of Plan participants and their beneficiaries (separately managed portfolios). The separately managed portfolios are composed primarily of investments in publicly traded common and preferred stocks. The asset classes are designed to provide participants with choices among a variety of investment objectives.
Payments of Benefits
Subject to Plan limitations, upon termination of employment, including termination due to disability (as defined in the Plan) or retirement, a participant may elect to receive a full or partial distribution of his or her account balance in: (a) a single payment in cash; (b) a single distribution in full shares of Amgen stock (with any fractional shares paid in cash); (c) a single distribution paid in a combination of cash and full shares of Amgen stock; or (d) a rollover distribution to an eligible retirement plan.
Participants may also elect to maintain their account balance in the Plan subsequent to termination of employment, provided that their account balance is greater than $1,000.
If a participant dies before receiving the value of his or her account balance, the participant’s beneficiary may elect to receive the distribution of remaining funds from among the alternatives described above, subject to certain Plan limitations.
Certain restrictions apply to withdrawals from the Plan while a participant continues to be employed by the Company, including special withdrawals by those affected by the COVID-19 emergency and associated lockdown, which were permitted under the Internal Revenue Circular Letter 20-23 (the Circular Letter) issued by the Puerto Rico Treasury Department (PRTD) on March 29, 2020. In response to the Circular Letter, the Company permitted eligible participants to initiate special withdrawals from the Plan through June 30, 2020 to help cover financial losses, unforeseen expenses, and necessities related to or resulting from: (a) the COVID-19 pandemic, (b) COVID-19-related medical treatment, and (c) compliance with governmental curfews and stay-at-home orders (Coronavirus-Related Withdrawals). As implemented by the Plan, eligible participants could request a Coronavirus-Related Withdrawal of up to $100,000, which was taxable at preferential tax rates. On June 22, 2020, the PRTD issued Circular Letter Number 20-29 extending the eligible period applicable to Coronavirus-Related Withdrawals, as a result of which the Plan extended the time to initiate Coronavirus-Related Withdrawals to September 30, 2020.

5



The Retirement and Savings Plan for Amgen Manufacturing, Limited
Notes to Financial Statements (continued)

Notes Receivable from Participants
Subject to certain restrictions, a participant can have up to two loans outstanding at any one time from his or her Plan account with a combined maximum loan amount that may not exceed the lesser of: (a) 50% of the participant’s account balance or (b) $50,000 less certain adjustments, as applicable (as defined in the Plan). A participant’s loan is secured by his or her Plan account balance. Loans made prior to January 1, 2006, bear interest at fixed rates based on the average borrowing rates of certain major banks. Loans made on or after January 1, 2006, bear interest at fixed rates which, until changed by the Company, are based on the prime rate plus one percentage point as published in The Wall Street Journal, determined as of the last day of the calendar quarter preceding origination or such other rate as may be required by law. Loans are generally payable in installments over periods ranging from one to five years, unless the loan is used to acquire a principal residence for which the term of the loan may be up to 20 years. Principal and interest payments are allocated to the participant’s account.
Plan Termination
Although it has not expressed any intent to do so, the Company has the right under the Plan to terminate the Plan subject to the provisions of ERISA. Upon termination, participants would receive distributions of their account balances.
Trustee and Custodians
Banco Popular de Puerto Rico is the Plan’s trustee. Bank of America, N.A. is the Plan’s custodian with respect to self-directed brokerage arrangement and the Amgen common stock fund. Northern Trust Company, NA (Northern) is the Plan’s custodian with respect to the asset classes.
2. Summary of Significant Accounting Policies
Basis of Accounting
The accompanying financial statements are prepared on the accrual basis of accounting. Benefits to participants are recorded when paid.
Fair Value Measurement
The investments of the Plan are reported at fair value. Fair value is generally defined as the price that would be received to sell an asset or paid to transfer a liability (the exit price) in an orderly transaction between market participants at the measurement date (see Note 3, Fair Value Measurements).
Investment Income and Losses
Dividend income is recognized on the ex-dividend date, and interest income is recorded on an accrual basis. Unrealized gains and losses on investments are measured by the change in the difference between the fair value and cost of the securities held at the beginning of the year (or date purchased if acquired during the Plan year) and the end of the year. Realized gains and losses from security transactions are recorded based on the weighted-average cost of securities sold.
Notes Receivable from Participants
Notes receivable from participants are carried at their unpaid balance plus accrued but unpaid interest, as applicable.
Due from/to Brokers
Purchases and sales of investments are recorded on a trade-date basis. Amounts due from and due to brokers arise from unsettled sale and purchase transactions, respectively.
Use of Estimates
The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
6



The Retirement and Savings Plan for Amgen Manufacturing, Limited
Notes to Financial Statements (continued)

3. Fair Value Measurements
The Plan uses various valuation approaches in determining the fair value of investments within a hierarchy that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the investment based on market data obtained from independent sources. Unobservable inputs are inputs that reflect assumptions about the inputs that market participants would use in pricing the investment and are developed based on the best information available in the circumstances. The fair value hierarchy is divided into three levels based on the source of inputs as follows:
Level 1 – Valuations based on unadjusted quoted prices in active markets for identical investments that the Plan has the ability to access;
Level 2 – Valuations for which all significant inputs are observable, either directly or indirectly, other than Level 1 inputs;
Level 3 – Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
The availability of observable inputs can vary among the various types of investments. To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used for measuring fair value may fall into different levels of the fair value hierarchy. In such cases, for financial statement disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is categorized is based on the lowest level of input used that is significant to the overall fair value measurement.
The following fair value hierarchy tables present information about each major class/category of the Plan’s investments measured at fair value:
 Fair value measurements at December 31, 2020, using
 Quoted prices
in active
markets for
identical
assets
(Level 1)
Significant
other
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
Total
Amgen stock$94,776,491 $— $— $94,776,491 
Cash and cash equivalents3,369,175 — — 3,369,175 
Collective trust funds— 375,624,863 — 375,624,863 
Common and preferred stock108,904,001 — — 108,904,001 
Mutual funds7,820,865 — — 7,820,865 
Self-directed brokerage accounts7,385,847 — — 7,385,847 
Total investments at fair value$222,256,379 $375,624,863 $— $597,881,242 
 
7



The Retirement and Savings Plan for Amgen Manufacturing, Limited
Notes to Financial Statements (continued)

 Fair value measurements at December 31, 2019, using
 Quoted prices
in  active
markets  for
identical
assets
(Level 1)
Significant
other
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
Total
Amgen stock$103,512,169 $— $— $103,512,169 
Cash and cash equivalents1,116,538 — — 1,116,538 
Collective trust funds— 305,516,006 — 305,516,006 
Common and preferred stocks91,588,716 329,692 — 91,918,408 
Mutual funds22,607,250 — — 22,607,250 
Self-directed brokerage accounts2,591,327 — — 2,591,327 
Total investments at fair value$221,416,000 $305,845,698 $— $527,261,698 
The fair values of substantially all common stocks (including Amgen stock), preferred stocks, mutual funds and underlying investments of self-directed brokerage accounts are valued using quoted market prices in active markets with no valuation adjustment.
Collective trust funds represent interests in pooled investment vehicles designed typically for collective investment of employee benefit trusts. The fair values of these investments are determined by reference to the net asset value per unit provided by the fund managers as the basis for current transactions.
4. Income Tax Status
The Plan received an opinion letter from the PRTD dated February 26, 2018, with an effective date of January 1, 2017, stating that the Plan meets the requirements of Section 1081.01 of the PR Code and the regulations thereunder, and, therefore the related trust forming part of the Plan is exempt from taxation. Subsequently, five amendments were made to the Plan, and the Plan received letters from the PRTD stating the PRTD has no objection to the first four of these amendments. The Company intends to submit the fifth amendment to the PRTD to request an opinion that the Plan remains in compliance with the PR Code and regulations thereunder. Once qualified, the Plan is required to operate in conformity with the PR Code to maintain its qualification.
For taxable year 2020, the Company believes the Plan satisfied, and operated in compliance with, the applicable requirements of the PR Code and therefore believes that the Plan, as amended, is qualified and the related trust is tax exempt. The Company has indicated that it currently intends to continue to take the necessary steps, if any, to maintain the Plan’s compliance with the applicable requirements of the Code.
5. Party-in-Interest Transactions
Parties-in-Interest are certain entities defined under Department of Labor regulations, including Amgen, and other parties that provide services to the Plan, such as the trustees, custodians and investment managers. The Plan pays the custodians certain administrative and investment management fees, and the Company pays certain administrative fees on behalf of the Plan. The Plan makes investments in collective trust funds managed by Northern, certain of the Plan’s investment managers and other third parties and may invest in securities of entities that are parties-in-interest. The Plan also invests in shares of common stock of Amgen and receives dividends on those shares. Notes receivable from participants are also considered party-in-interest transactions.
8



The Retirement and Savings Plan for Amgen Manufacturing, Limited
Notes to Financial Statements (continued)

6. Reconciliation of Financial Statements to Form 5500
The reconciliation of net assets available for benefits per the financial statements to the Form 5500 consisted of the following:
 December 31,
 20202019
Net assets available for benefits per the financial statements$611,614,673 $543,047,506 
Amounts allocated to withdrawing participants— (24,938)
Deemed loans(595,252)(485,301)
Net assets per the Form 5500$611,019,421 $542,537,267 
The following is a reconciliation of expenses per the financial statements to the Form 5500:
 Year Ended
December 31,
2020
Benefits paid$(36,610,267)
Investment and administrative fees(726,345)
Total expenses per the financial statements(37,336,612)
Amounts allocated to withdrawing participants at December 31, 202024,938 
Deemed loans at December 31, 2019485,301 
Deemed loans at December 31, 2020(595,252)
Total expenses per the Form 5500$(37,421,625)
9


Supplemental Schedule
The Retirement and Savings Plan for Amgen Manufacturing, Limited
EIN: 98-0210484 Plan: #001
As of December 31, 2020
Schedule H, line 4i – Schedule of Assets (Held at End of Year)
Identity of IssueDescription of InvestmentCurrent Value
Amgen Stock*Employer Securities 412,215 shares$94,776,491 
$94,776,491 
Capital Preservation Asset Class:
Wells Fargo Stable Value Fund W*Collective Trust Fund 1,100,345 units64,451,122 
NT Collective Short Term Investment Fund*Collective Trust Fund 4,282,466 units4,282,466 
Total Capital Preservation Asset Class68,733,588 
Fixed Income Active Asset Class:
Wellington Core Bond Plus Portfolio Collective Investment Trust II*Collective Trust Fund 2,106,172 units28,896,679 
MetLife Core Plus Collective Fund*Collective Trust Fund 2,646,927 units28,825,037 
Putnam Absolute Return Fixed Income Fund*Collective Trust Fund 105,132 units8,072,067 
Schroder Global Strategic Bond Trust Class W*Collective Trust Fund 774,365 units7,921,749 
Northern Trust Global Investments Collective Daily Aggregate Bond Index Fund - Non Lending*Collective Trust Fund 39,019 units6,404,238 
Total Fixed Income Active Asset Class80,119,770 
Fixed Income Index Asset Class:
NT Collective Aggregate Bond Index Fund / Non Lending*Collective Trust Fund 357,221 units58,630,656 
Total Fixed Income Index Asset Class58,630,656 
U.S. Equity Active Asset Class:
NT Collective Russell 3000 Index Fund / Non Lending*Collective Trust Fund 96,420 units5,650,098 
Interest Bearing CashCash and Cash Equivalents 3,365,484 units3,365,484 
Amazon Inc.Common and Preferred Stock 642 shares3,123,396 
Visa Inc. Class A Common and Preferred Stock 8,413 shares3,081,687 
Facebook Inc.Common and Preferred Stock 6,108 shares2,358,190 
Microsoft CorporationCommon and Preferred Stock 8,029 shares1,785,810 
General Electric CompanyCommon and Preferred Stock 78,797 shares1,629,482 
Sea LimitedCommon and Preferred Stock 7,895 shares1,571,500 
Salesforce.com Inc. Common and Preferred Stock 7,041 shares1,566,834 
Alphabet Inc.Common and Preferred Stock 851 shares1,490,850 
Mastercard Inc. Class ACommon and Preferred Stock 4,114 shares1,468,451 
Match Group Inc.Common and Preferred Stock 2,283 shares1,302,351 
Netflix, Inc.Common and Preferred Stock 2,406 shares1,300,996 
Square Inc Class ACommon and Preferred Stock 5,740 shares1,249,254 
TransDigm Group Inc.Common and Preferred Stock 1,967 shares1,217,278 
CoStar Group Inc.Common and Preferred Stock 1,316 shares1,216,352 
ServiceNow Inc.Common and Preferred Stock 2,027 shares1,115,722 
10



Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)

Identity of IssueDescription of InvestmentCurrent Value
Intuit Inc.Common and Preferred Stock 982 shares990,269 
KKR & Company Inc. Class ACommon and Preferred Stock 24,411 shares988,401 
The Carlyle Group Inc.Common and Preferred Stock 31,427 shares988,065 
Anthem Inc.Common and Preferred Stock 2,915 shares935,977 
Skyworks Solutions IncCommon and Preferred Stock 6,040 shares923,395 
Northern Trust Global Investments Collective Daily Short Term Investment Fund - Non Lending*Collective Trust Fund 921,355 units921,355 
Uber Technologies Inc.Common and Preferred Stock 18,033 shares919,683 
Illumina, Inc.Common and Preferred Stock 1,411 shares902,430 
Heico Corporation Class ACommon and Preferred Stock 4,469 shares895,626 
Jones Lang LaSalle Inc.Common and Preferred Stock 5,774 shares856,688 
Qorvo, Inc.Common and Preferred Stock 5,082 shares844,984 
UnitedHealth Group Inc.Common and Preferred Stock 2,298 shares805,863 
Entegris Inc.Common and Preferred Stock 8,151 shares783,311 
Paypal Holdings Inc.Common and Preferred Stock 3,304 shares773,797 
Hilton Worldwide Holdings Inc.Common and Preferred Stock 6,633 shares737,988 
Adobe Systems Inc. Common and Preferred Stock 1,471 shares735,677 
American International Group Inc.*Common and Preferred Stock 19,275 shares729,752 
FleetCor Technologies Inc.Common and Preferred Stock 2,659 shares725,455 
Twilio Inc. Class ACommon and Preferred Stock 2,131 shares721,344 
Abbott LaboratoriesCommon and Preferred Stock 6,501 shares711,794 
SS&C Technologies Holdings Inc.Common and Preferred Stock 8,745 shares709,967 
Charles River Laboratories International Inc.Common and Preferred Stock 1,808 shares708,353 
Yum! Brands Inc.Common and Preferred Stock 6,484 shares703,903 
Catalent Inc.Common and Preferred Stock 4,359 shares686,758 
Clean Harbors Inc.Common and Preferred Stock 2,906 shares680,638 
Workday Inc. Class ACommon and Preferred Stock 2,803 shares671,627 
Wayfair Inc. Class ACommon and Preferred Stock 2,959 shares668,172 
STERIS plcCommon and Preferred Stock 1,981 shares664,527 
Capital One Financial CorporationCommon and Preferred Stock 6,719 shares664,173 
Autodesk Inc.Common and Preferred Stock 2,155 shares658,008 
Wells Fargo & Company*Common and Preferred Stock 21,667 shares653,910 
Citigroup Inc.Common and Preferred Stock 10,510 shares648,047 
Halozyme Therapeutics Inc.Common and Preferred Stock 14,592 shares623,224 
Nike Inc. Class BCommon and Preferred Stock 4,404 shares623,034 
Synopsys Inc.Common and Preferred Stock 2,384 shares618,028 
Union Pacific CorporationCommon and Preferred Stock 2,950 shares614,249 
Align Technology Inc.Common and Preferred Stock 1,136 shares607,056 
Newell Brands Inc.Common and Preferred Stock 4,835 shares595,608 
Compass Group PLCCommon and Preferred Stock 31,137 shares580,130 
Ball CorporationCommon and Preferred Stock 6,104 shares568,771 
Gildan Activewear Inc.Common and Preferred Stock 19,958 shares559,024 
Merit Medical Systems Inc.Common and Preferred Stock 6,166 shares556,044 
Waste Connections Inc.Common and Preferred Stock 5,409 shares554,801 
Baker Hughes CompanyCommon and Preferred Stock 26,188 shares546,020 
Lear CorporationCommon and Preferred Stock 3,423 shares544,360 
11



Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)

Identity of IssueDescription of InvestmentCurrent Value
Zoetis Inc. Class ACommon and Preferred Stock 3,289 shares544,330 
Equinix Inc.Common and Preferred Stock 742 shares529,922 
Thermo Fisher CorporationCommon and Preferred Stock 1,130 shares526,331 
NRG Energy Inc.Common and Preferred Stock 14,005 shares525,888 
IHS Markit LimitedCommon and Preferred Stock 5,810 shares521,912 
FMC CorporationCommon and Preferred Stock 4,517 shares519,139 
Danaher CorporationCommon and Preferred Stock 2,327 shares516,920 
Charter Communications, Inc. Class ACommon and Preferred Stock 781 shares516,671 
Wabtec CorporationCommon and Preferred Stock 437 shares513,498 
Woodward Inc.Common and Preferred Stock 961 shares505,808 
MetLife Inc.*Common and Preferred Stock 10,563 shares495,933 
Equitable Holdings Inc.Common and Preferred Stock 19,324 shares494,501 
PVH CorporationCommon and Preferred Stock 5,217 shares489,824 
Halliburton CompanyCommon and Preferred Stock 25,688 shares485,503 
J2 Global Inc.Common and Preferred Stock 4,946 shares483,175 
Goldman Sachs Group Inc.Common and Preferred Stock 1,830 shares482,589 
Regeneron Pharmaceuticals, Inc.Common and Preferred Stock 998 shares482,144 
Intuitive Surgical, Inc. Common and Preferred Stock 583 shares476,942 
Ford Motor CompanyCommon and Preferred Stock 53,773 shares472,665 
Zillow Group Inc. Class CCommon and Preferred Stock 3,636 shares471,953 
Ametek Inc.Common and Preferred Stock 3,841 shares464,531 
Skechers USA Inc. Class ACommon and Preferred Stock 12,567 shares451,658 
Amphenol Corporation Class ACommon and Preferred Stock 3,399 shares444,487 
Linde PLCCommon and Preferred Stock 1,680 shares442,697 
Warner Music Group Corporation Class ACommon and Preferred Stock 11,391 shares432,744 
Ritchie Bros Auctioneers Inc.Common and Preferred Stock 6,140 shares427,037 
UGI CorporationCommon and Preferred Stock 12,170 shares425,463 
Euronet Worldwide Inc.Common and Preferred Stock 1,779 shares416,355 
National Oilwell Varco, Inc.Common and Preferred Stock 30,087 shares413,095 
Mohawk Industries Inc.Common and Preferred Stock 2,929 shares412,843 
Textron Inc.Common and Preferred Stock 8,492 shares410,418 
On Semiconductor CorporationCommon and Preferred Stock 12,512 shares409,518 
Sensata Technologies BV HoldingCommon and Preferred Stock 7,732 shares407,786 
Voya Financial Inc.Common and Preferred Stock 1,217 shares407,730 
Hewlett Packard Enterprise CompanyCommon and Preferred Stock 34,290 shares406,337 
Dow Inc.Common and Preferred Stock 7,265 shares403,208 
Floor & Decor Holdings Inc.Common and Preferred Stock 4,337 shares402,690 
Axis Capital Holdings LimitedCommon and Preferred Stock 7,982 shares402,213 
KAR Auction Services Inc.Common and Preferred Stock 21,544 shares400,934 
TCF Financial CorporationCommon and Preferred Stock 7,514 shares384,675 
MSCI Inc.Common and Preferred Stock 845 shares377,318 
Biotelemetry Inc.Common and Preferred Stock 5,169 shares372,582 
Walt Disney CompanyCommon and Preferred Stock 2,025 shares366,890 
Helen Trustoy LimitedCommon and Preferred Stock 1,635 shares363,281 
IDEX CorporationCommon and Preferred Stock 1,138 shares362,345 
Whitbread PLCCommon and Preferred Stock 8,438 shares357,564 
12



Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)

Identity of IssueDescription of InvestmentCurrent Value
Proofpoint Inc.Common and Preferred Stock 2,100 shares356,985 
Sally Beauty Holdings Inc.Common and Preferred Stock 27,240 shares355,210 
Copart Inc.Common and Preferred Stock 2,759 shares351,083 
American Express CompanyCommon and Preferred Stock 2,897 shares350,276 
Hanesbrands Inc.Common and Preferred Stock 23,211 shares338,416 
Trinet Group Inc.Common and Preferred Stock 4,193 shares337,956 
Western Alliance BancorporationCommon and Preferred Stock 5,600 shares335,720 
Atlassian Corporation PLC Class ACommon and Preferred Stock 1,431 shares334,668 
CVS Health CorporationCommon and Preferred Stock 4,882 shares333,441 
BWX Technologies Inc.Common and Preferred Stock 5,519 shares332,685 
Gartner Inc.Common and Preferred Stock 1,372 shares331,273 
JP Morgan Chase & Company*Common and Preferred Stock 2,591 shares329,238 
Bank of America Corporation*Common and Preferred Stock 10,764 shares326,257 
Cognizant Technology Solutions Corporation Class ACommon and Preferred Stock 3,978 shares325,997 
Edison InternationalCommon and Preferred Stock 5,173 shares324,968 
McKesson CorporationCommon and Preferred Stock 1,868 shares324,883 
Belden Inc.Common and Preferred Stock 4,785 shares320,367 
Morgan StanleyCommon and Preferred Stock 4,673 shares320,241 
Edwards Lifesciences CorporationCommon and Preferred Stock 3,479 shares317,389 
ABM Industrials Inc.Common and Preferred Stock 8,304 shares314,223 
HealthEquity Inc.Common and Preferred Stock 3,112 shares304,842 
2U Inc.Common and Preferred Stock 7,455 shares298,275 
Henry Schein Inc.Common and Preferred Stock 4,430 shares296,190 
Dollar Tree Inc.Common and Preferred Stock 2,722 shares294,085 
Carter Inc.Common and Preferred Stock 1,162 shares286,161 
LKQ CorporationCommon and Preferred Stock 7,899 shares278,361 
Generac Holdings Inc.Common and Preferred Stock 1,220 shares277,440 
Quidel CorporationCommon and Preferred Stock 1,226 shares275,583 
Pluralsight Inc. Class ACommon and Preferred Stock 13,085 shares274,262 
Keysight Technologies Inc.Common and Preferred Stock 2,035 shares268,803 
Grocery Outlet Holding CorporationCommon and Preferred Stock 6,608 shares259,364 
Fiverr International LimitedCommon and Preferred Stock 1,329 shares259,288 
Matson Inc.Common and Preferred Stock 4,421 shares251,864 
UBS Group AGCommon and Preferred Stock 17,398 shares245,834 
Syneos Health Inc.Common and Preferred Stock 3,604 shares245,541 
Ingredion Inc.Common and Preferred Stock 3,087 shares242,854 
IAA Spinco Inc.Common and Preferred Stock 3,659 shares237,762 
Royal Dutch Shell PLCCommon and Preferred Stock 6,756 shares237,406 
Airbnb Inc. Class ACommon and Preferred Stock 1,608 shares236,054 
Itron Inc.Common and Preferred Stock 851 shares230,831 
Coupa Software Inc.Common and Preferred Stock 678 shares229,781 
Bio-Techne CorporationCommon and Preferred Stock 709 shares225,143 
Mednax Inc.Common and Preferred Stock 6,117 shares224,983 
Kirby CorporationCommon and Preferred Stock 4,338 shares224,839 
Frontdoor Inc.Common and Preferred Stock 4,468 shares224,338 
13



Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)

Identity of IssueDescription of InvestmentCurrent Value
Graco Inc.Common and Preferred Stock 3,017 shares218,280 
HMS Holdings CorporationCommon and Preferred Stock 5,927 shares217,817 
MACOM Technology Solutions Holdings Inc.Common and Preferred Stock 3,911 shares215,261 
Advanced Energy Industries Inc.Common and Preferred Stock 2,200 shares213,334 
Cardinal Health, Inc.Common and Preferred Stock 3,930 shares210,491 
Dexcom Inc.Common and Preferred Stock 551 shares203,716 
Hologic Inc.Common and Preferred Stock 2,786 shares202,904 
Tennant CompanyCommon and Preferred Stock 2,874 shares201,669 
Trimble Inc.Common and Preferred Stock 3,017 shares201,445 
Bottomline Technologies Inc.Common and Preferred Stock 3,766 shares198,619 
Prosperity Bancshares Inc.Common and Preferred Stock 2,855 shares198,023 
DoorDash Inc. Class ACommon and Preferred Stock 1,384 shares197,566 
Solarwinds CorporationCommon and Preferred Stock 13,197 shares197,295 
QTS Realty Trust Inc. Class ACommon and Preferred Stock 3,164 shares195,788 
Dycom Industries Inc.Common and Preferred Stock 2,589 shares195,521 
Chemed CorporationCommon and Preferred Stock 362 shares192,805 
Nuance Communications Inc.Common and Preferred Stock 4,358 shares192,144 
Middleby CorporationCommon and Preferred Stock 1,477 shares190,415 
ASGN Inc.Common and Preferred Stock 2,271 shares189,697 
FTI Consulting Inc.Common and Preferred Stock 1,665 shares186,014 
First American Financial CorporationCommon and Preferred Stock 3,557 shares183,648 
LPL Financial Holdings Inc.Common and Preferred Stock 1,760 shares183,427 
C.H. Robinson Worldwide Inc.Common and Preferred Stock 1,948 shares182,859 
Acadia Healthcare Company Inc.Common and Preferred Stock 3,618 shares181,841 
Snowflake Inc. Class ACommon and Preferred Stock 638 shares179,533 
Cenovus Energy Inc.Common and Preferred Stock 29,590 shares178,724 
Mid-American Apartment Communities Inc.Common and Preferred Stock 1,388 shares175,846 
BankUnited Inc.Common and Preferred Stock 5,036 shares175,152 
ACI Worldwide Inc.Common and Preferred Stock 4,534 shares174,242 
Cabot CorporationCommon and Preferred Stock 3,856 shares173,057 
8X8 Inc.Common and Preferred Stock 5,017 shares172,936 
Viatris Inc.Common and Preferred Stock 9,204 shares172,483 
Harsco CorporationCommon and Preferred Stock 9,551 shares171,727 
Booking Holdings Inc.Common and Preferred Stock 77 shares171,500 
Pacific Premier Bancorp Inc.Common and Preferred Stock 5,410 shares169,495 
ALLETE Inc.Common and Preferred Stock 2,697 shares167,052 
John Bean Technologies CorporationCommon and Preferred Stock 1,437 shares163,631 
Altra Industrial Motion CorporationCommon and Preferred Stock 2,942 shares163,075 
Shutterstock Inc.Common and Preferred Stock 2,222 shares159,317 
AMN Healthcare Services Inc.Common and Preferred Stock 2,328 shares158,886 
Atmos Energy CorporationCommon and Preferred Stock 1,657 shares158,128 
Cohen & Steers Inc.Common and Preferred Stock 2,116 shares157,219 
Vroom Inc.Common and Preferred Stock 3,822 shares156,587 
Wolverine World Wide Inc.Common and Preferred Stock 4,999 shares156,219 
NCR CorporationCommon and Preferred Stock 4,096 shares153,887 
Cooper Companies Inc.Common and Preferred Stock 418 shares151,868 
14



Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)

Identity of IssueDescription of InvestmentCurrent Value
FLIR Systems Inc.Common and Preferred Stock 3,447 shares151,082 
Kodiak Sciences Inc.Common and Preferred Stock 1,028 shares151,023 
AptarGroup Inc.Common and Preferred Stock 1,103 shares150,990 
Exxon Mobil CorporationCommon and Preferred Stock 3,663 shares150,989 
Rogers CorporationCommon and Preferred Stock 959 shares148,923 
Albany International Corporation Class ACommon and Preferred Stock 2,011 shares147,648 
AerCap Holdings N.V.Common and Preferred Stock 3,232 shares147,315 
National Retail Properties Inc.Common and Preferred Stock 3,588 shares146,821 
Forward Air CorporationCommon and Preferred Stock 1,909 shares146,688 
Evercore Inc.Common and Preferred Stock 1,333 shares146,150 
National Bank Holdings Corporation Class ACommon and Preferred Stock 4,412 shares144,537 
Hexcel CorporationCommon and Preferred Stock 2,952 shares143,142 
Omnicell Inc.Common and Preferred Stock 1,190 shares142,824 
Herbalife Nutrition LimitedCommon and Preferred Stock 2,884 shares138,576 
IPG Photonics CorporationCommon and Preferred Stock 618 shares138,302 
Heron Therapeutics Inc.Common and Preferred Stock 6,421 shares135,900 
Axogen Inc.Common and Preferred Stock 7,554 shares135,217 
WisdomTree Investments Inc.Common and Preferred Stock 25,234 shares135,002 
Aspen Technology Inc.Common and Preferred Stock 1,029 shares134,027 
Monro Inc.Common and Preferred Stock 2,506 shares133,570 
Nasdaq Inc.Common and Preferred Stock 987 shares131,014 
Alleghany CorporationCommon and Preferred Stock 217 shares131,001 
Knowles CorporationCommon and Preferred Stock 7,031 shares129,581 
Revance Therapeutics Inc.Common and Preferred Stock 4,537 shares128,579 
Cimpress PLCCommon and Preferred Stock 1,465 shares128,539 
iShares Russell Mid-Cap ETFMutual Fund 1,820 units124,761 
iShares Russell 2000 ETFMutual Fund 633 units124,106 
Exact Sciences CorporationCommon and Preferred Stock 923 shares122,288 
FireEye Inc.Common and Preferred Stock 5,287 shares121,918 
New Relic Inc.Common and Preferred Stock 1,841 shares120,401 
Sarepta Therapeutics Inc.Common and Preferred Stock 705 shares120,195 
Abiomed Inc.Common and Preferred Stock 366 shares118,657 
Signature BankCommon and Preferred Stock 863 shares116,755 
Tronox Holdings PLCCommon and Preferred Stock 7,876 shares115,147 
Sotera Health CompanyCommon and Preferred Stock 4,034 shares110,693 
JBG SMITH PropertiesCommon and Preferred Stock 3,516 shares109,945 
SLR Investment CorporationCommon and Preferred Stock 1,316 shares108,089 
Graphic Packaging Holding CompanyCommon and Preferred Stock 6,246 shares105,807 
Markel Corporation Holding CompanyCommon and Preferred Stock 102 shares105,397 
Kraton CorporationCommon and Preferred Stock 3,788 shares105,269 
Integra Lifesciences Holding CorporationCommon and Preferred Stock 1,619 shares105,105 
Alamos Gold Inc. Class ACommon and Preferred Stock 11,759 shares102,891 
Polaris Inc.Common and Preferred Stock 1,069 shares101,854 
Neurocrine Biosciences Inc.Common and Preferred Stock 1,040 shares99,684 
Grand Canyon Education Inc.Common and Preferred Stock 1,069 shares99,535 
CarGurus Inc. Class ACommon and Preferred Stock 3,087 shares97,951 
15



Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)

Identity of IssueDescription of InvestmentCurrent Value
Matthews International Corporation Class ACommon and Preferred Stock 3,305 shares97,167 
Huron Consulting Group Inc.Common and Preferred Stock 1,632 shares96,206 
Bank OzkCommon and Preferred Stock 3,021 shares94,467 
TreeHouse Foods Inc.Common and Preferred Stock 2,202 shares93,563 
Deciphera Pharmaceuticals Inc.Common and Preferred Stock 1,610 shares91,883 
Fox Factory Holding CorporationCommon and Preferred Stock 855 shares90,382 
Carlisle Companies Inc.Common and Preferred Stock 571 shares89,179 
KBR, Inc.Common and Preferred Stock 2,870 shares88,769 
Agios Pharmaceuticals Inc.Common and Preferred Stock 2,030 shares87,960 
BRP Group Inc. Class ACommon and Preferred Stock 2,919 shares87,482 
1-800-FLOWERS.COM Inc. Class ACommon and Preferred Stock 3,288 shares85,488 
Barnes Group Inc.Common and Preferred Stock 1,670 shares84,652 
Knight-Swift Transportation Holdings Inc. Class ACommon and Preferred Stock 2,000 shares83,640 
Masimo CorporationCommon and Preferred Stock 311 shares83,466 
AZZ Inc.Common and Preferred Stock 1,754 shares83,210 
Ontrak Inc.Common and Preferred Stock 1,333 shares82,366 
Nu Skin Enterprises Inc. Class ACommon and Preferred Stock 1,506 shares82,273 
Coherus BioSciences Inc.Common and Preferred Stock 4,729 shares82,190 
Encompass Health CorporationCommon and Preferred Stock 973 shares80,457 
SpringWorks Therapeutics Inc.Common and Preferred Stock 1,097 shares79,554 
Team Inc.Common and Preferred Stock 7,251 shares79,036 
WillScot Mobile Mini Holdings CorporationCommon and Preferred Stock 3,403 shares78,848 
Boston Properties Inc.Common and Preferred Stock 829 shares78,365 
Flowserve CorporationCommon and Preferred Stock 2,083 shares76,759 
Albemarle CorporationCommon and Preferred Stock 519 shares76,563 
Texas Capital Bancshares Inc.Common and Preferred Stock 906,815 shares74,970 
WSFS Financial CorporationCommon and Preferred Stock 1,658 shares74,411 
CalAmp CorporationCommon and Preferred Stock 7,475 shares74,152 
Supernus Pharmaceuticals Inc.Common and Preferred Stock 2,946 shares74,121 
Kennametal Inc. CapitalCommon and Preferred Stock 2,045 shares74,111 
Allakos Inc.Common and Preferred Stock 529 shares74,060 
World Wrestling EntertainmentCommon and Preferred Stock 1,510 shares72,556 
Haemonetics CorporationCommon and Preferred Stock 610 shares72,438 
PacWest BancorpCommon and Preferred Stock 2,819 shares71,603 
Prestige Consumer Healthcare Inc.Common and Preferred Stock 2,021 shares70,472 
Nevro CorporationCommon and Preferred Stock 407 shares70,452 
Ciena CorporationCommon and Preferred Stock 1,327 shares70,132 
Cal/Maine Foods Inc.Common and Preferred Stock 1,819 shares68,285 
Northwestern CorporationCommon and Preferred Stock 1,156 shares67,406 
Heartland Express Inc.Common and Preferred Stock 3,678 shares66,572 
Viking Therapeutics Inc.Common and Preferred Stock 11,229 shares63,219 
iShares Core S&P Small-Cap ETFMutual Fund 655 units60,195 
Infinera CorporationCommon and Preferred Stock 5,335 shares55,911 
Berkshire Hills Bancorp Inc.Common and Preferred Stock 3,216 shares55,058 
Mirati Therapeutics Inc.Common and Preferred Stock 246 shares54,031 
16



Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)

Identity of IssueDescription of InvestmentCurrent Value
Wix.com LimitedCommon and Preferred Stock 216 shares53,991 
Xperi Holding CorporationCommon and Preferred Stock 2,578 shares53,880 
Sumo Logic Inc.Common and Preferred Stock 1,825 shares52,159 
Silgan Holdings Inc.Common and Preferred Stock 1,250 shares46,350 
John Wiley & Sons Inc. Class ACommon and Preferred Stock 939 shares42,875 
Range Resources CorporationCommon and Preferred Stock 6,264 shares41,969 
Banner CorporationCommon and Preferred Stock 851 shares39,648 
Arvinas Inc.Common and Preferred Stock 427 shares36,265 
Fulton Financial CorporationCommon and Preferred Stock 2,823 shares35,909 
Designer Brands Inc. Class ACommon and Preferred Stock 4,132 shares31,610 
Amdocs LimitedCommon and Preferred Stock 410 shares29,081 
STAG Industrial Inc.Common and Preferred Stock 911 shares28,533 
NexTier Oilfield Solutions Inc.Common and Preferred Stock 7,643 shares26,292 
Oceaneering International Inc.Common and Preferred Stock 3,241 shares25,766 
QEP Resources Inc.Common and Preferred Stock 10,275 shares24,557 
RPC Inc.Common and Preferred Stock 3,421 shares10,776 
Total U.S. Equity Active Asset Class119,150,000 
U.S. Equity Index Asset Class:
NT Collective Russell 3000 Index Fund / Non Lending*Collective Trust Fund 1,396,699 units81,845,182 
Northern Trust Global Investments Collective Daily Short Term Investment Fund - Non Lending*Collective Trust Fund 30,292 units30,292 
Total U.S. Equity Index Asset Class81,875,474 
International Equity Active Asset Class:
Polaris Capital Management Collective Investment Trust International Value Collective Fund*Collective Trust Fund 1,099,189 units11,857,064 
Mawer International Equity Collective Investment Trust Class B*Collective Trust Fund 693,512 units11,342,669 
Reliance Trust Institutional Retirement Trust GQG Partners International Equity Fund Series 11 Class C*Collective Trust Fund 755,584 units9,286,132 
Dodge & Cox International FundMutual Fund 171,562 units7,497,264 
Wilmington Trust Collective Investment Trust / Jennison International Equity Opportunities CIT Class J*Collective Trust Fund 640,000 units6,860,800 
NT Collective MSCI All Country World Index (ACWI) ex/US Index Fund / Non Lending*Collective Trust Fund 18,657 units3,786,502 
BlackRock FTSE RAFI Emerging Index Non Lendable Fund F*Collective Trust Fund 1,675 units7,813 
Northern Trust Global Investments Collective Daily Short Term Investment Fund - Non Lending*Collective Trust Fund 553 units553 
Total International Equity Active Asset Class50,638,797 
International Equity Index Asset Class:
NT Collective MSCI All Country World Index (ACWI) ex/US Index Fund / Non Lending (Tier J)*Collective Trust Fund 197,263 units36,554,840 
Total International Equity Index Asset Class36,554,840 
17



Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)

Identity of IssueDescription of InvestmentCurrent Value
Participant Self-Directed AccountsVarious Investments7,385,847 
7,385,847 
Notes Receivable from Participants*Interest Rate 4.25% - 9.25%13,121,785 
13,121,785 
Other:
Northern Trust Global Investments Collective Daily Short Term Investment Fund - Non Lending*Collective Trust Fund 12,088 units12,088 
BIF Money Fund*Cash and Cash Equivalents 3,691 units3,691 
Total Other15,779 
Grand Total$611,003,027 
* Indicates party-in-interest

18


THE RETIREMENT AND SAVINGS PLAN FOR
AMGEN MANUFACTURING, LIMITED
INDEX TO EXHIBIT
 
  Exhibit 23.1
19


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  
 The Retirement and Savings Plan for
 Amgen Manufacturing, Limited
 (Name of Plan)
Date:June 22, 2021 By: /s/ PETER H. GRIFFITH
   Peter H. Griffith
   
Deputy Chairman and Chief Financial Officer
Amgen Manufacturing, Limited
20
Document


Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 33-47605, 333-144580 and 333-216715) pertaining to The Retirement and Savings Plan for Amgen Manufacturing, Limited of Amgen Inc. of our report dated June 22, 2021, with respect to the financial statements and schedule of The Retirement and Savings Plan for Amgen Manufacturing, Limited included in this Annual Report (Form 11-K) for the year ended December 31, 2020.

/s/ ERNST & YOUNG LLP
Los Angeles, California
June 22, 2021